Skip to main content
Clinical Trials/NCT06880809
NCT06880809RecruitingNot Applicable

Bridging the Gap: A Collaborative Intervention Group for Black Youth at Risk for Suicide

Children's Hospital Los Angeles1 site in 1 country16 target enrollmentStarted: June 1, 2025Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
16
Locations
1
Primary Endpoint
The Collaborative Assessment & Management of Suicidality - Suicide Status Form (SSF)

Study Overview

Brief Summary

The goal of this clinical trial is to develop and preliminarily test a culturally adapted suicide intervention specifically for black youth. The main question it aims to answer:

-To evaluate the feasibility and acceptability of the group, as well as the preliminary efficacy of the group for decreasing suicidal thoughts and behaviors and increasing protective factors such as hope, positive ethnic identity, and family and peer support.

Participants will be asked to attend 10-week group intervention and complete pre-treatment and post-treatment assessment measures.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
12 Years to 17 Years (Child)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •12-17 years old
  • •Identify as Black or African American or being of African descent
  • •Have current suicidal ideation or suicidal ideation within the last 30 days
  • •Have assent from the adolescent participant and consent from an individual's caregiver or guardian to participate.

Exclusion Criteria

  • •An active psychotic disorder or current psychosis symptoms
  • •No history of suicide attempt(s) or suicide ideation in the past 30 days
  • •Cognitive deficits or a medical condition diagnosed from a medical provider that precludes full understanding of study materials as assessed through an inability to complete the pre-treatment CAMS SSF & SSP
  • •Caregivers, guardians, and/or the patient refuse to participate.

Arms & Interventions

Treatment Arm

Experimental

Participants will complete a 10-week group and complete pre-treatment and post-treatment assessment measures.

Intervention: Bridge the Gap (BTG) - Black Youth Group (Behavioral)

Outcomes

Primary Outcomes

The Collaborative Assessment & Management of Suicidality - Suicide Status Form (SSF)

Time Frame: From pre-treatment until 3 months post-treatment, approximately 23 weeks.

An assessment of suicide risk that consists of six core assessment constructs: psychological pain, stress, agitation, hopelessness, self-hate, and overall risk of suicide; as well as reasons for living and reasons for dying constructs, and wish to live and wish to die constructs.

Ethnic Identity Scale (EIS)

Time Frame: From baseline until 3 months post-treatment, approximately 22 weeks.

A 17-item scale that assesses the three components of ethnic identity and distinguishes between exploration, resolution, and affirmation. Scores range from 17-68, with higher scores indicating higher levels of affirmation, exploration, and resolution.

Living Ladder Scale

Time Frame: From baseline until 3 months post-treatment, approximately 22 weeks.

A one-item measure that is prospectively associated with suicidal ideation and suicide attempts by measuring readiness to continue living among individuals thinking of suicide. Scores range from 0-8, with 8 indicating an individual is committed to making changes to make their lives worth living.

Brief Suicide Cognitions Scale (B-SCS)

Time Frame: From baseline until 3 months post-treatment, approximately 22 weeks.

A 6-item self-report scale that measures the suicidal belief system, including dimensions of unlovability, unbearability, and unsolvability. Scores range from 6-30, with lower scores indicating fewer suicide cognitions.

Therapeutic Relationship Working Alliance Inventory, Short Revised (WAI-SR)

Time Frame: From baseline until 3 months post-treatment, approximately 22 weeks.

A 12-item scale that reflects Bordin's three-dimensional conceptualization of therapeutic alliance: task, goal, and bond. Scores range from 12-60, with higher scores indicating higher therapeutic alliance.

Optimism and Hope Scale (OHS)

Time Frame: From baseline until 3 months post-treatment, approximately 22 weeks.

A 14-item scale that measures an individual's level of both optimism, as characterized by a positive outlook on the future, and hope, as characterized by the belief in one's ability to achieve goals and navigate challenges. Scores range from 14-56, with lower scores indicating more hope and optimism.

Parent Readiness for Hospital Discharge Scale (RHDS)

Time Frame: From baseline until 3 months post-treatment, approximately 22 weeks.

A 23-item scale aimed at providing a discharge readiness assessment before pediatric discharge from care in hospital settings. Scores range from 0-80, with higher scores indicating more readiness.

Group Cohesion Scale

Time Frame: From baseline until the beginning of post-treatment, approximately 10 weeks.

A 12-item self-report scale that measures group cohesion, including dimensions of engagement, conflict, and avoidance. Scores across the subscales range from 0-72; higher scores indicate more of that dimension.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Tia Tyndal

Principle Investigator, Licensed Clinical Psychologist

Children's Hospital Los Angeles

Study Sites (1)

Loading locations...

Similar Trials

Bridge the Gap (BTG) - Black Youth Group | Clinical Trial